UPDATE on Increased Rate of Major Adverse Cardiac Events Observed in Patients Receiving Abbott Vascular’s Absorb GT1 Bioresorbable Vascular Scaffold (BVS) - Letter to Health Care Providers |
10/31/2017 |
Type III Endoleaks Associated with Endovascular Graft Systems - Letter to Health Care Providers |
09/28/2017 |
UPDATE on SynCardia Systems - TAH-t Companion 2 Driver System (C2) and Freedom Driver System - Letter to Health Care Providers |
09/25/2017 |
Information about the Use of Forced Air Thermal Regulating Systems - Letter to Health Care Providers |
08/30/2017 |
UPDATE: Potential risks with liquid-filled intragastric balloons -- Letter to Health Care Providers |
08/10/2017 |
UPDATE: Severe Bleeding and Hematomas Associated with VASCU-GUARD Peripheral Vascular Patch – Letter to Health Care Providers |
07/06/2017 |
The Use of Non-Medtronic Devices with Medtronic’s NavLock Tracker– Letter to Health Care Providers |
05/02/2017 |
Neurovascular Thrombus Retrieval Catheters and Guide Catheters Used During Neurological Interventional Procedures: Differences in FDA Review and Intended Use - Letter to Health Care Providers |
03/01/2017 |